Spurred by megadeals, global healthcare private equity deal value soared to $115 billion in 2024, the second-highest total on record
Despite high borrowing costs and extended hold times in 2024, dealmaking roared ahead for healthcare private equity with a heavy focus on biopharmaNorth American and European deal activity surged in


